Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review Publisher Pubmed



Eskandarieh S1, 2 ; Heydarpour P1 ; Minagar A3 ; Pourmand S1 ; Sahraian MA1
Authors
Show Affiliations
Authors Affiliations
  1. 1. MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Brain and Spinal Cord Injury Research Center, Neuoroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Neurology, LSU Health Sciences Center, Shreveport, LA, United States

Source: Neuroepidemiology Published:2016


Abstract

Background: Multiple sclerosis (MS) is one of the most common chronic immune-mediated diseases of the human central nervous system and an important cause of non-traumatic neurologic disability among young population in several countries. Recent reports from East Asia, South East Asia and South Asia have proposed a low to moderate prevalence of MS in these countries. Methods: A literature review search was carried out in December 2014 in Medline, Embase, Scopus and Cochrane library to recover original population-based studies on MS epidemiology in East Asia, South East Asia and South Asia countries published between January 1, 1950 and December 30, 2014. We intended search strategies using the key words: multiple sclerosis, prevalence, incidence and epidemiology. Based on our inclusion criteria, 68 epidemiologic studies were included in this systematic review. Results: The most extensively used diagnostic criteria in the studies were McDonald's criteria. Most studies were performed in a multi-center hospital setting. The female to male ratio varied and ranged from 0.7 in India to 9.0 in China. The mean age at disease onset ranged from the lowest age of 25.3 in Iran to the highest age of 46.4 in China. MS prevalence ranged from 0.77 in 100,000 populations in Hong Kong (1999) to 85.80 in 100,000 in Iran (2013). Conclusions: Advances in MS registries around the globe allow nationwide population-based studies and will allow worldly comparisons between the prevalence and incidence in different regions that are provided to monitor estimation. © 2016 S. Karger AG, Basel.
Other Related Docs
12. Prevalence and Incidence of Multiple Sclerosis in Ardabil, Northwest of Iran, Multiple Sclerosis and Related Disorders (2021)
21. Fluoxetine for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)
25. Blood Concentrations of Cadmium and Lead in Multiple Sclerosis Patients From Iran, Iranian Journal of Pharmaceutical Research (2016)
27. Prevalence and Predictors of Dysphagia in Iranian Patients With Multiple Sclerosis, Medical Journal of the Islamic Republic of Iran (2017)
34. Blood Lead Levels and Multiple Sclerosis: A Case-Control Study, Multiple Sclerosis and Related Disorders (2019)
43. History of Multiple Sclerosis in Iran, Archives of Iranian Medicine (2020)
50. Registry-Based Incidence of Multiple Sclerosis in Southwestern Iran, 2001-2014, Bangladesh Medical Research Council Bulletin (2016)